Two Long-Established Independent IRBs Discussing Merger
Independent Review Consulting (IRC) an independent Institutional Review Board (IRB) founded in 1984 announced that it has entered into a preliminary agreement to merge with the Ethical Review Committee (ERC), another central IRB providing reviews of research on behalf of subject safety since 1988. Erica Heath, founder of Independent Review Consulting (IRC), accredited by the Association for the Accreditation of Human Research Protection Program, Inc. (AAHRPP) and located in Northern California is in talks with Terri Majors, President of the Ethical Review Committee (ERC) in Missouri. Under the terms of the proposed merger, the two organizations will begin implementing an integration plan immediately while they continue to operate as their respective organizations. The first phase of the plan will be the formation of Ethical and Independent Review Services (E&I), a new Limited Liability Corporation to provide management services for both entities. Both companies have experience in the review of late-stage, multi- center trials. While IRC specializes in medical devices and federally funded studies, ERC has developed processes specializing in efficient turn-around of large, late-stage multi-center trials.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Beyond the Molecule: How Human-Centered Design Unlocks AI's Promise in Pharma
June 23rd 2025How human-centered AI that is focused on customer, user, and employee experience can drive real transformation in clinical trials and beyond by aligning intelligent technologies with the people who use them.
2025 DIA Annual Meeting: Why AI and Automation Are Set to Become the New Normal in Clinical Research
June 20th 2025Peter Ronco, CEO, Emmes, shares his long-term vision for artificial intelligence in clinical research, from making automation routine to improving drug discovery, transforming regulatory oversight, reducing animal testing, and promoting ethical, equitable data use worldwide.
